label: The E2/E3 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3).
label_lc: the e2/e3 combination of apoe isoforms is considered lower risk with a 0.6 odds ratio for the development of alzheimer's disease versus the most common combination of apoe isoforms (e3/e3).